650 filings
Page 13 of 33
425
fx7xjw extj
21 Feb 17
Business combination disclosure
12:00am
8-K
fy4n y9n6tfsu6
6 Jan 17
This presentation contains forward-looking statements, including, but not limited to, statements regarding
12:00am
425
72t7h9d dw
6 Jan 17
Business combination disclosure
12:00am
425
8o0vet89mdqs8bp lv6
6 Jan 17
Business combination disclosure
12:00am
425
gxnwi3rkm326pmop0e9m
5 Jan 17
Business combination disclosure
12:00am
8-K
jno6 sysv17a
5 Jan 17
Announce Definitive Merger Agreement
12:00am
8-K
jztldbd5741k
17 Nov 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
id42n3ov
10 Nov 16
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016
12:00am
8-K
b7qx9kdx
28 Oct 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
dt29i
25 Oct 16
OncoGenex Announces Positive Survival Results from Apatorsen Phase 2
12:00am
8-K
5rkcf3o uupnth44bvb
13 Oct 16
OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer
12:00am
8-K
uc4qb63d7pld1b
22 Aug 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
j5mo8z7p
16 Aug 16
Other Events
12:00am
8-K
tnym28
4 Aug 16
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2016
12:00am
8-K
96azcv2 zhdp6ypk
20 Jun 16
Other Events
12:00am
8-K
804mvz
1 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
z9or u90dou6
12 May 16
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016
12:00am